Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can become severely limiting despite medicines, oxygen therapy, pulmonary rehabilitation and other treatments.
For a small group of people with very advanced COPD, lung transplantation may become a treatment option when the disease continues to worsen and the expected risks of remaining without a transplant become significant.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
However, having severe COPD does not automatically mean that a lung transplant is needed or that a person will be listed for transplantation.
The decision is based on the severity and progression of the disease, overall health, expected survival without transplantation, response to available treatments and whether the person is medically suitable for a transplant.
If you are living with advanced COPD and wondering when transplantation may be considered, understanding the evaluation process described as part of lung transplant surgery can help put the decision into perspective.
When Can Lung Transplant Be Considered for COPD?
Lung transplantation is generally considered when COPD has reached an advanced stage and continues to cause significant health problems despite appropriate treatment.
The transplant team looks for evidence that the disease is severe enough to substantially affect life expectancy or daily functioning, while also considering whether the person is likely to benefit from transplantation.
Importantly, there is no single measurement that determines whether someone with COPD should receive a transplant. Several clinical and functional factors are considered together.
Why Isn't Severe COPD Alone Enough for a Lung Transplant?
COPD can be severe without transplantation being the next step. Some people with advanced COPD may remain stable for a considerable period with comprehensive medical management, while others experience rapid deterioration.
This variation makes transplant timing particularly individualised. The transplant team needs to determine whether the potential benefits of transplantation justify the risks of a major operation and lifelong immunosuppressive treatment. For this reason, referral for transplant evaluation and actual listing for transplantation are two different decisions.
What Is the Difference Between Referral and Listing?
Referral means that a patient is sent to a transplant centre for a detailed assessment. It does not mean that transplantation will definitely be performed.
During the evaluation, the transplant team assesses lung disease severity, other medical conditions, physical condition, nutritional status, previous treatments and other factors that could affect transplant suitability.
Listing is a later decision made after a detailed evaluation. A patient is considered for active transplantation when the transplant team determines that the expected benefits and risks are appropriate and that the person meets the relevant selection criteria.
Early referral can therefore be useful even when immediate transplantation is not expected. It gives the patient and medical team time to identify and address factors that may affect future candidacy.
What COPD Features May Lead to a Lung Transplant Evaluation?
Several features can indicate that a person with COPD may need assessment for transplantation. These may include:
- Severe airflow limitation despite optimal treatment
- Progressive worsening of lung function
- Increasing breathlessness and functional limitation
- Repeated severe COPD exacerbations
- Hospitalisations related to COPD
- Long-term oxygen requirement
- Chronic high carbon dioxide levels in the blood
- Pulmonary hypertension associated with advanced COPD
- Significant reduction in exercise capacity
No single feature automatically means that transplantation is required. The overall pattern and progression of the disease are more important than one measurement considered on its own.
How Is Lung Function Used When Considering Transplant for COPD?
One of the key measurements used in COPD is forced expiratory volume in one second, commonly called FEV1. It measures how much air a person can forcefully breathe out during the first second of a pulmonary function test.
A very low FEV1 indicates severe airflow limitation. International transplant guidance identifies an FEV1 below 20% of the predicted value as one factor that may support consideration of listing in an appropriate patient.
However, FEV1 is not used by itself. Prognosis in advanced COPD can vary considerably between individuals, so the transplant team considers several other measures alongside lung function.
What Is the BODE Index?
The BODE index is a multidimensional tool that can help assess the severity and prognosis of COPD. The name comes from four factors:
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
- B – Body mass index (BMI)
- O – Airflow obstruction, measured using FEV1
- D – Dyspnoea, or the degree of breathlessness
- E – Exercise capacity, commonly assessed using the six-minute walk test
Unlike relying only on FEV1, the BODE index combines lung function with physical condition, breathlessness and exercise capacity.
A high BODE score can indicate advanced disease and increased mortality risk. However, the BODE index is not a perfect predictor of survival. The transplant team considers it together with the patient's overall clinical picture.
Why Do COPD Exacerbations Matter?
A COPD exacerbation is a period when respiratory symptoms become significantly worse than the person's usual condition. Severe exacerbations may require emergency treatment or hospitalisation.
Repeated or severe exacerbations can indicate that COPD is becoming increasingly difficult to control and may be associated with a poorer prognosis.
Particularly severe exacerbations involving hospitalisation, respiratory failure or significant changes in blood oxygen or carbon dioxide levels may influence the decision to refer someone for transplant assessment.
Does Pulmonary Hypertension Affect Lung Transplant Decisions?
Yes. Pulmonary hypertension can develop in people with advanced COPD and may place additional strain on the right side of the heart.
When significant pulmonary hypertension occurs alongside severe COPD, it can indicate more advanced disease and may influence transplant assessment and timing.
The transplant team may use echocardiography, imaging, blood tests and, when appropriate, right-heart catheterisation to assess pulmonary pressures and cardiac function.
Does Oxygen Dependence Mean a Lung Transplant Is Needed?
Not necessarily. Long-term oxygen therapy is commonly used in advanced COPD, but requiring oxygen alone does not automatically make someone a lung transplant candidate.
However, increasing oxygen requirements combined with severe airflow limitation, worsening exercise capacity, repeated exacerbations or other signs of progressive disease may support referral for transplant evaluation.
Single or Double Lung Transplant for COPD?
People with advanced COPD may be considered for either single or bilateral lung transplantation, depending on their individual circumstances and the transplant team's assessment.
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
The choice can be influenced by factors such as age, other medical conditions, lung anatomy, pulmonary pressures and the patient's overall condition.
There is no single approach that is appropriate for every person with COPD. The transplant team evaluates the potential benefits and risks of each option for the individual patient.
What Happens During a Lung Transplant Evaluation for COPD?
*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
A transplant evaluation is a detailed process rather than a single appointment. Depending on the transplant centre and the patient's circumstances, it may involve:
- Detailed medical and smoking history
- Pulmonary function testing
- Six-minute walk or other exercise testing
- Blood tests
- Chest imaging
- Cardiac assessment
- Assessment of nutritional and physical condition
- Screening for infections and other medical conditions
- Assessment of transplant-related risks
The purpose is to determine whether transplantation is appropriate, identify factors that can be improved and establish the patient's medical condition before any decision about listing is made.
Does Age Determine Whether Someone With COPD Can Have a Lung Transplant?
Age is one factor considered during transplant assessment, but it is not interpreted in isolation. As age increases, other health conditions and frailty may become more important in determining the risks associated with transplantation.
The transplant team therefore considers biological health, physical condition, organ function and other risk factors alongside chronological age. Individual transplant programmes may also have their own criteria and approaches to assessing age-related risk.
The Bottom Line
Lung transplantation can be an option for a carefully selected group of people with very advanced COPD, particularly when the disease continues to progress despite appropriate treatment and is associated with a significant risk of poor outcomes.
The decision is not based on one number or symptom. Lung function, BODE score, breathlessness, exercise capacity, exacerbations, oxygen requirements, pulmonary hypertension, chronic hypercapnia and overall health may all contribute to the assessment.
Referral and listing are also different stages. A person may be referred to a transplant centre well before transplantation becomes necessary, allowing time for detailed evaluation, optimisation of health and monitoring of disease progression.
Ultimately, the decision to proceed with transplantation is individualised. The transplant team weighs the expected course of advanced COPD against the potential benefits and risks of major surgery and lifelong post-transplant care.
